Healthcare News

Global Wearable Injectors Market Expected to Reach US$ 13.0 Bn by 2024: According to BlueWeave Consulting

Press Release

According to a market report published by BlueWeave Consulting, The Global Wearable Injectors Market is expected to reach a value of US$ 13.0 Bn by 2024, owing to growing burden of geriatric population, increasing prevalence of chronic diseases, high demand for advanced drug delivery and increasing compliance for controlled drug delivery. The emerging economies offer ample growth opportunities for the global of wearable injectors market.

However, alternative drug delivery methods hinder the growth of the global market. The market is projected to expand at a CAGR of 23.0% during the forecast period from 2018 to 2024 by value.

Access PDF Sample of this Research [email protected] https://www.blueweaveconsulting.com/wearable-injectors-market#ReportSample/     

Accelerating pervasiveness of chronic diseases is driving the market growth

The demand for wearable injectors is increasing due to increasing prevalence of chronic and lifestyle associated diseases. The prevalence of chronic diseases, such as heart disease, cancer, stroke, and diabetes, is increasing due to the alteration in lifestyle and lack of access to preventive care. As reported by WHO in 2014, there were 422 million adults suffering from diabetes. Eastern Mediterranean region had the highest prevalence of diabetes (13.7%) in 2014, followed by South-East Asia (8.6%). According to Centre for Disease Control and Prevention (CDC), approximately 117 million people in 2012 in the U.S. had one or more chronic health conditions.

Wearable Injectors Market: Scope of the Report  

The wearable injectors market can be segmented on the basis type, technology, application, end user and geography. Based on type, the global wearable injectors market is classified into body-worn patch injector, off-body worn belt injector, and bolus injector. Bolus injector market is expected to witness the fastest growth and is expected to grow at a  CAGR of 42.36% during the forecast period. In end-user segment, the sale of wearable injectors in homecare segment is dominating.

North America is expected to lead the global wearable injectors market during the forecast period

North America led the global wearable injectors market; owing to rise in ageing population in the region the market has witness gain in terms of revenue in 2017. The North American wearable injectors market is expected to grow at a CAGR of 24.48% during the period 2018– 2024.

Global Wearable Injectors Market: Competitive Dynamics

The research study includes profiles of leading companies operating in the global Wearable Injectors market. Some of the key players profiled in the report include Johnson & Johnson, Medtronic plc, F. Hoffmann-La Roche Ltd, Unilife Corporation, etc.

Browse full list of Table of [email protected]

https://www.blueweaveconsulting.com/wearable-injectors-market#TOC/

About BlueWeave Consulting & Research Pvt Ltd. (BWC)

BlueWeave Consulting provides a full scope of business intelligence solution for solving your toughest challenges. BWC is an emerging global expert & pioneer in the market research and provision of exclusive market INTEL. We optimize your decision making by equipping your industry with an accurate & better market research according to your industry demands through our professionally designed qualitative & quantitative research methods. Our trendy & efficient sample collection methods, integrated data solutions as well as methodologies certainly make us a better partner that you can rely on. With collective experience in the varied fields of retail, market research and reporting, we provide the business insight and business practices that would give the required impetus for your company’s growth.

Contact Us:

[email protected]

https://www.blueweaveconsulting.com

Global Contact: +1 866 658 6826